Improving the purification of recombinant proteins by the use of ionic liquids as adjuvants in aqueous two-phase systems

Detalhes bibliográficos
Autor(a) principal: Castro, Leonor S.
Data de Publicação: 2019
Outros Autores: Almeida, Mafalda R., Pereira, Patrícia, Passarinha, Luís, Sousa, Fani, Coutinho, João A. P., Tavares, Ana P. M., Pedro, Augusto Q., Freire, Mara G.
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10773/28742
Resumo: The development of new drugs has a high impact on the global health, and since the approval of humulin (recombinant insulin) by FDA, several protein-based biopharmaceuticals have been introduced in the market. These products are usually attained through biotechnological processes using engineered biological sources and have led to remarkable advances in the treatment of distinct human diseases, as for example the case of interferon alfa 2b (IFNα2b) which has been used in in the treatment of oncological diseases for more than 30 years [1]. Currently, the (bio)pharmaceutical industry is committed to improve the quality of their products while endeavouring a reduction of its production costs, which is intimately related to the necessity of improving their downstream processes, since this field is mainly dominated by chromatographic techniques [2] and are responsible for their current high-cost. Therefore, envisaging to develop new, cost-effective, efficient and sustainable techniques for proteins purification, polymer-polymer aqueous two-phase systems (ATPS) with ionic liquids (ILs) as adjuvants are herein proposed for the extraction and purification of IFNα2b from Escherichia coli BL21 cultures. The recombinant protein was produced in the form of inclusion bodies, followed by a dialysis step in order to solubilize the target biomolecule in a specific buffer, with the goal of maintaining the biomolecule stability. Afterwards, several polymers where studied as phase-forming components of ATPS, namely polyethylene glycol (PEG), polypropylene glycol (PPG), as well as Dextran. Furthermore, several ILs belonging to the cholinium, imidazolium, tetralkylammonium and tetralkylphosphonium families, were tested as co-adjuvants for ATPS formation in order to extract and purify of IFNα2b.
id RCAP_3bd3a1a9649ec4119d51eec890431f81
oai_identifier_str oai:ria.ua.pt:10773/28742
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Improving the purification of recombinant proteins by the use of ionic liquids as adjuvants in aqueous two-phase systemsThe development of new drugs has a high impact on the global health, and since the approval of humulin (recombinant insulin) by FDA, several protein-based biopharmaceuticals have been introduced in the market. These products are usually attained through biotechnological processes using engineered biological sources and have led to remarkable advances in the treatment of distinct human diseases, as for example the case of interferon alfa 2b (IFNα2b) which has been used in in the treatment of oncological diseases for more than 30 years [1]. Currently, the (bio)pharmaceutical industry is committed to improve the quality of their products while endeavouring a reduction of its production costs, which is intimately related to the necessity of improving their downstream processes, since this field is mainly dominated by chromatographic techniques [2] and are responsible for their current high-cost. Therefore, envisaging to develop new, cost-effective, efficient and sustainable techniques for proteins purification, polymer-polymer aqueous two-phase systems (ATPS) with ionic liquids (ILs) as adjuvants are herein proposed for the extraction and purification of IFNα2b from Escherichia coli BL21 cultures. The recombinant protein was produced in the form of inclusion bodies, followed by a dialysis step in order to solubilize the target biomolecule in a specific buffer, with the goal of maintaining the biomolecule stability. Afterwards, several polymers where studied as phase-forming components of ATPS, namely polyethylene glycol (PEG), polypropylene glycol (PPG), as well as Dextran. Furthermore, several ILs belonging to the cholinium, imidazolium, tetralkylammonium and tetralkylphosphonium families, were tested as co-adjuvants for ATPS formation in order to extract and purify of IFNα2b.2020-06-29T14:37:47Z2019-01-01T00:00:00Z2019conference objectinfo:eu-repo/semantics/publishedVersionapplication/mswordhttp://hdl.handle.net/10773/28742engCastro, Leonor S.Almeida, Mafalda R.Pereira, PatríciaPassarinha, LuísSousa, FaniCoutinho, João A. P.Tavares, Ana P. M.Pedro, Augusto Q.Freire, Mara G.info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-05-06T04:26:19Zoai:ria.ua.pt:10773/28742Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-05-06T04:26:19Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Improving the purification of recombinant proteins by the use of ionic liquids as adjuvants in aqueous two-phase systems
title Improving the purification of recombinant proteins by the use of ionic liquids as adjuvants in aqueous two-phase systems
spellingShingle Improving the purification of recombinant proteins by the use of ionic liquids as adjuvants in aqueous two-phase systems
Castro, Leonor S.
title_short Improving the purification of recombinant proteins by the use of ionic liquids as adjuvants in aqueous two-phase systems
title_full Improving the purification of recombinant proteins by the use of ionic liquids as adjuvants in aqueous two-phase systems
title_fullStr Improving the purification of recombinant proteins by the use of ionic liquids as adjuvants in aqueous two-phase systems
title_full_unstemmed Improving the purification of recombinant proteins by the use of ionic liquids as adjuvants in aqueous two-phase systems
title_sort Improving the purification of recombinant proteins by the use of ionic liquids as adjuvants in aqueous two-phase systems
author Castro, Leonor S.
author_facet Castro, Leonor S.
Almeida, Mafalda R.
Pereira, Patrícia
Passarinha, Luís
Sousa, Fani
Coutinho, João A. P.
Tavares, Ana P. M.
Pedro, Augusto Q.
Freire, Mara G.
author_role author
author2 Almeida, Mafalda R.
Pereira, Patrícia
Passarinha, Luís
Sousa, Fani
Coutinho, João A. P.
Tavares, Ana P. M.
Pedro, Augusto Q.
Freire, Mara G.
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Castro, Leonor S.
Almeida, Mafalda R.
Pereira, Patrícia
Passarinha, Luís
Sousa, Fani
Coutinho, João A. P.
Tavares, Ana P. M.
Pedro, Augusto Q.
Freire, Mara G.
description The development of new drugs has a high impact on the global health, and since the approval of humulin (recombinant insulin) by FDA, several protein-based biopharmaceuticals have been introduced in the market. These products are usually attained through biotechnological processes using engineered biological sources and have led to remarkable advances in the treatment of distinct human diseases, as for example the case of interferon alfa 2b (IFNα2b) which has been used in in the treatment of oncological diseases for more than 30 years [1]. Currently, the (bio)pharmaceutical industry is committed to improve the quality of their products while endeavouring a reduction of its production costs, which is intimately related to the necessity of improving their downstream processes, since this field is mainly dominated by chromatographic techniques [2] and are responsible for their current high-cost. Therefore, envisaging to develop new, cost-effective, efficient and sustainable techniques for proteins purification, polymer-polymer aqueous two-phase systems (ATPS) with ionic liquids (ILs) as adjuvants are herein proposed for the extraction and purification of IFNα2b from Escherichia coli BL21 cultures. The recombinant protein was produced in the form of inclusion bodies, followed by a dialysis step in order to solubilize the target biomolecule in a specific buffer, with the goal of maintaining the biomolecule stability. Afterwards, several polymers where studied as phase-forming components of ATPS, namely polyethylene glycol (PEG), polypropylene glycol (PPG), as well as Dextran. Furthermore, several ILs belonging to the cholinium, imidazolium, tetralkylammonium and tetralkylphosphonium families, were tested as co-adjuvants for ATPS formation in order to extract and purify of IFNα2b.
publishDate 2019
dc.date.none.fl_str_mv 2019-01-01T00:00:00Z
2019
2020-06-29T14:37:47Z
dc.type.driver.fl_str_mv conference object
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10773/28742
url http://hdl.handle.net/10773/28742
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/msword
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv mluisa.alvim@gmail.com
_version_ 1817543745382383616